Literature DB >> 21217192

Police investigation into multidrug-resistant acinetobacter baumannii outbreak in Japan.

Koichiro Yuji, Giichiro Oiso, Tomoko Matsumura, Naoko Murashige, Masahiro Kami.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21217192     DOI: 10.1093/cid/ciq081

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  6 in total

1.  Lytic myophage Abp53 encodes several proteins similar to those encoded by host Acinetobacter baumannii and phage phiKO2.

Authors:  Chia-Ni Lee; Tsai-Tien Tseng; Juey-Wen Lin; Yung-Chieh Fu; Shu-Fen Weng; Yi-Hsiung Tseng
Journal:  Appl Environ Microbiol       Date:  2011-08-05       Impact factor: 4.792

Review 2.  Infection control in healthcare settings in Japan.

Authors:  Keita Morikane
Journal:  J Epidemiol       Date:  2012-02-04       Impact factor: 3.211

3.  Bactericidal activities of woven cotton and nonwoven polypropylene fabrics coated with hydroxyapatite-binding silver/titanium dioxide ceramic nanocomposite "Earth-plus".

Authors:  Eriko Kasuga; Yoshiyuki Kawakami; Takehisa Matsumoto; Eiko Hidaka; Kozue Oana; Naoko Ogiwara; Dai Yamaki; Tsukasa Sakurada; Takayuki Honda
Journal:  Int J Nanomedicine       Date:  2011-09-09

Review 4.  Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens.

Authors:  Kyungwon Lee; Dongeun Yong; Seok Hoon Jeong; Yunsop Chong
Journal:  Yonsei Med J       Date:  2011-11       Impact factor: 2.759

5.  Genomic analysis of antibiotic resistance for Acinetobacter baumannii in a critical care center.

Authors:  Kensuke Murata; Yoshiaki Inoue; Mayuko Kaiho; Takeshi Nakazawa; Shin-Ichi Sasaki; Kazunori Miyake; Shigeru Matsuda; Hiroshi Tanaka
Journal:  Acute Med Surg       Date:  2019-07-22

6.  Comparative analysis of the pathogenicity between multidrug-resistant Acinetobacter baumannii clinical isolates: isolation of highly pathogenic multidrug-resistant A. baumannii and experimental therapeutics with fourth-generation cephalosporin cefozopran.

Authors:  Satoshi Nishida; Yasuo Ono
Journal:  Infect Drug Resist       Date:  2018-10-10       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.